Current Practices and Recent Advances in Perioperative Pain Management for Liver Transplantation Living Donors and Recipients.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
08 Oct 2024
08 Oct 2024
Historique:
medline:
8
10
2024
pubmed:
8
10
2024
entrez:
8
10
2024
Statut:
aheadofprint
Résumé
Analgesia in liver transplantation patients has been traditionally considered a secondary priority where perioperative management principally focused on survival rates in these critically ill patients. With recent advancements in both surgical and medical management, posttransplant survival rates have steadily improved. Outcome measurements are no longer limited to short-term mortality rates and hospital length of stay but are also measured by patient-centered outcomes, such as pain control and quality of life. As living donor liver transplantation has increased access to transplantation, it has also added a different patient population to manage in the perioperative period. For healthy patients undergoing living donor hepatectomies, it is important to reduce the impact of the surgery with proper perioperative pain management. We performed a literature search for articles related to perioperative pain management for liver transplantation living donors and recipients to identify current practices and recent advances. Neuraxial techniques, peripheral nerve blocks, and enteral and parenteral medications were all found to be feasible analgesia modalities for patients undergoing either liver transplant or donor hepatectomy. Patients may also benefit from nonpharmacological interventions and preoperative counseling. No particular perioperative analgesic modality was deemed superior to any other. For liver transplant living donors and recipients, perioperative pain management should emphasize the application of sustainable patient-centered pain control protocols.
Identifiants
pubmed: 39375901
doi: 10.1097/TP.0000000000005239
pii: 00007890-990000000-00893
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no funding or conflicts of interest.
Références
Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg. 2000;232:490–500.
Kwong AJ, Ebel NH, Kim WR, et al. OPTN/SRTR 2021 annual data report: liver. Am J Transplant. 2023;23:S178–S263.
Randall HB, Alhamad T, Schnitzler MA, et al. Survival implications of opioid use before and after liver transplantation. Liver Transpl. 2017;23:305–314.
Rogal S, Mankaney G, Udawatta V, et al. Association between opioid use and readmission following liver transplantation. Clin Transplant. 2016;30:1222–1229.
Fleming JN, Taber DJ, Pilch NA, et al. Association of pretransplantion opioid use with graft loss or death in liver transplantation patients with model of end-stage liver disease exceptions. J Am Coll Surg. 2018;226:651–659.
Fukazawa K, Rodriguez PJ, Fong CT, et al. Perioperative opioid use and chronic post-surgical pain after liver transplantation: a single center observational study. J Cardiothorac Vasc Anesth. 2020;34:1815–1821.
Cron DC, Tincopa MA, Lee JS, et al. Prevalence and patterns of opioid use before and after liver transplantation. Transplantation. 2021;105:100–107.
Johnson-Laghi KA, Woo SM, Zafar Z, et al. Alcohol-associated liver disease predicts increased post-liver transplant opioid use. Clin Transplant. 2022;36:e14811.
Moon AM, Watkins SE, Lok AS, et al. Opioid use is more common in nonalcoholic fatty liver disease patients with cirrhosis, higher BMI, and psychiatric disease. Dig Dis. 2021;39:247–257.
Sussman J, Calderon E, Ubl DS, et al. Variation in opioid prescribing patterns after abdominal transplant surgery. Clin Transplant. 2021;35:e14439.
Butt Z, DiMartini AF, Liu Q, et al. Fatigue, pain, and other physical symptoms of living liver donors in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2018;24:1221–1232.
Mandell MS, Smith AR, Dew MA, et al. Early postoperative pain and its predictors in the adult to adult living donor liver transplantation cohort study. Transplantation. 2016;100:2362–2371.
Tseng SC, Lee WC, Chen KH, et al. Anxiety, pain intensity, and decision regret of living liver donors during postoperative period. Appl Nurs Res. 2023;69:151662.
Tatara T, Nagao K, Kinoshita M, et al. A case report of epidural hematoma after partial liver resection. J JPN Soc Clin Anesth. 2008;28:325–329.
Su J, Soliz JM, Popat KU, et al. Incidence of epidural hematoma from use of epidural analgesia for hepatic resection surgery: a retrospective study. J Clin Anesth. 2020;62:109719.
Jacquenod P, Wallon G, Gazon M, et al. Incidence and risk factors of coagulation profile derangement after liver surgery: implications for the use of epidural analgesia—a retrospective cohort study. Anesth Analg. 2018;126:1142–1147.
Karna ST, Pandey CK, Sharma S, et al. Postoperative coagulopathy after live related donor hepatectomy: incidence, predictors and implications for safety of thoracic epidural catheter. J Postgrad Med. 2015;61:176–180.
Koul A, Pant D, Rudravaram S, et al. Thoracic epidural analgesia in donor hepatectomy: an analysis. Liver Transpl. 2018;24:214–221.
Atalan HK, Gucyetmez B, Donmez R, et al. Advantages of epidural analgesia on pulmonary functions in liver transplant donors. Transplant Proc. 2017;49:1351–1356.
Tang JZJ, Weinberg L. A literature review of intrathecal morphine analgesia in patients undergoing major open hepato-pancreatic-biliary (HPB) surgery. Anesth Pain Med. 2019;9:e94441.
Tang J, Churilov L, Tan CO, et al. Intrathecal morphine is associated with reduction in postoperative opioid requirements and improvement in postoperative analgesia in patients undergoing open liver resection. BMC Anesthesiol. 2020;20:207.
Hasselstrom J, Eriksson S, Persson A, et al. The metabolism and bioavailability of morphine in patients with severe liver cirrhosis. Br J Clin Pharmacol. 1990;29:289–297.
Kotb HI, El-Kady SA, Emara SE, et al. Pharmacokinetics of controlled release morphine (MST) in patients with liver carcinoma. Br J Anaesth. 2005;94:95–99.
Rudin A, Lundberg JF, Hammarlund-Udenaes M, et al. Morphine metabolism after major liver surgery. Anesth Analg. 2007;104:1409–1414, table of contents.
Moss CR, Caldwell JC, Afilaka B, et al. Hepatic resection is associated with reduced postoperative opioid requirement. J Anaesthesiol Clin Pharmacol. 2016;32:307–313.
Hacibeyoglu G, Topal A, Arican S, et al. USG guided bilateral erector spinae plane block is an effective and safe postoperative analgesia method for living donor liver transplantation. J Clin Anesth. 2018;49:36–37.
Mistry K, Hutchins J, Leiting J, et al. Continuous paravertebral infusions as an effective adjunct for postoperative pain management in living liver donors: a retrospective observational study. Transplant Proc. 2017;49:309–315.
Adelmann D, Khorashadi M, Zhou G, et al. “The use of bilateral continuous erector spinae plane blocks for postoperative analgesia after right-sided living donor hepatectomy: a feasibility study.” Clin Transplant. 2021;35:e14413.
Kang R, Chin KJ, Kim GS, et al. Bilateral continuous erector spinae plane block using a programmed intermittent bolus regimen versus intrathecal morphine for postoperative analgesia in living donor laparoscopic hepatectomy: a randomized controlled trial. J Clin Anesth. 2021;75:110479.
Zubair M, Adil Khan M, Khan MNA, et al. Comparison of continuous thoracic epidural with erector spinae block for postoperative analgesia in adult living donor hepatectomy. Cureus. 2022;14:e23151.
Kitlik A, Erdogan MA, Ozgul U, et al. Ultrasound-guided transversus abdominis plane block for postoperative analgesia in living liver donors: a prospective, randomized, double-blinded clinical trial. J Clin Anesth. 2017;37:103–107.
Gitman M, Fettiplace MR, Weinberg GL, et al. Local anesthetic systemic toxicity: a narrative literature review and clinical update on prevention, diagnosis, and management. Plast Reconstr Surg. 2019;144:783–795.
Sharma A, Goel AD, Sharma PP, et al. The effect of transversus abdominis plane block for analgesia in patients undergoing liver transplantation: a systematic review and meta-analysis. Turk J Anaesthesiol Reanim. 2019;47:359–366.
Erdogan MA, Ozgul U, Uçar M, et al. Effect of transversus abdominis plane block in combination with general anesthesia on perioperative opioid consumption, hemodynamics, and recovery in living liver donors: the prospective, double-blinded, randomized study. Clin Transplant. 2017;31:e12931.
Maeda A, Shibata SC, Wada H, et al. The efficacy of continuous subcostal transversus abdominis plane block for analgesia after living liver donation: a retrospective study. J Anesth. 2016;30:39–46.
Amundson AW, Olsen DA, Smith HM, et al. Acute benefits after liposomal bupivacaine abdominal wall blockade for living liver donation: a retrospective review. Mayo Clin Proc Innov Qual Outcomes. 2018;2:186–193.
Hughes MJ, Harrison EM, Peel NJ, et al. Randomized clinical trial of perioperative nerve block and continuous local anaesthetic infiltration via wound catheter versus epidural analgesia in open liver resection (LIVER 2 trial). Br J Surg. 2015;102:1619–1628.
Bell R, Ward D, Jeffery J, et al. A randomized controlled trial comparing epidural analgesia versus continuous local anesthetic infiltration via abdominal wound catheter in open liver resection. Ann Surg. 2019;269:413–419.
Khan J, Katz J, Montbriand J, et al. Surgically placed abdominal wall catheters on postoperative analgesia and outcomes after living liver donation. Liver Transpl. 2015;21:478–486.
Xin Y, Hong Y, Yong LZ. Efficacy of postoperative continuous wound infiltration with local anesthesia after open hepatectomy. Clin J Pain. 2014;30:571–576.
Gavriilidis P, Roberts KJ, Sutcliffe RP. Local anaesthetic infiltration via wound catheter versus epidural analgesia in open hepatectomy: a systematic review and meta-analysis of randomised controlled trials. HPB (Oxford). 2019;21:945–952.
Sadik H, Watson N, Dilaver N, et al. Efficacy of local anaesthetic infiltration via wound catheters after open hepatic surgery: a systematic review and meta-analysis. HPB (Oxford). 2023;25:1–13.
Elsharkawy H, El-Boghdadly K, Barrington M. Quadratus lumborum block: anatomical concepts, mechanisms, and techniques. Anesthesiology. 2019;130:322–335.
Lee S, Kang RA, Kim GS, et al. Comparison of postoperative analgesic effects of posterior quadratus lumborum block and intrathecal morphine in laparoscopic donor hepatectomy: a prospective randomized non-inferiority clinical trial. Reg Anesth Pain Med. 2022;47:527–533.
Liotiri D, Diamantis A, Papapetrou E, et al. External oblique intercostal (EOI) block for enhanced recovery after liver surgery: a case series. Anaesth Rep. 2023;11:e12225.
Elsharkawy H, Kolli S, Soliman LM, et al. The external oblique intercostal block: anatomic evaluation and case series. Pain Med. 2021;22:2436–2442.
Cosarcan SK, Ercelen O. The analgesic contribution of external oblique intercostal block: case reports of 3 different surgeries and 3 spectacular effects. Medicine (Baltimore). 2022;101:e30435.
Waurick R, Van Aken H. Update in thoracic epidural anaesthesia. Best Pract Res Clin Anaesthesiol. 2005;19:201–213.
Paladini G, Di Carlo S, Musella G, et al. Continuous wound infiltration of local anesthetics in postoperative pain management: safety, efficacy and current perspectives. J Pain Res. 2020;13:285–294.
Krishnan S, Cascella M: Erector Spinae Plane Block. StatPearls. 2024
Pai SL, Aniskevich S, Rodrigues ES, et al. Analgesic considerations for liver transplantation patients. Curr Clin Pharmacol. 2015;10:54–65.
Frye RF, Zgheib NK, Matzke GR, et al. Liver disease selectively modulates cytochrome P450-mediated metabolism. Clin Pharmacol Ther. 2006;80:235–245.
Labroo RB, Paine MF, Thummel KE, et al. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metab Dispos. 1997;25:1072–1080.
Sudarshan G, Browne BL, Matthews JN, et al. Intrathecal fentanyl for post-thoracotomy pain. Br J Anaesth. 1995;75:19–22.
Chaplan SR, Duncan SR, Brodsky JB, et al. Morphine and hydromorphone epidural analgesia. A prospective, randomized comparison. Anesthesiology. 1992;77:1090–1094.
Charnin JE, Weingarten TN, Schroeder DR, et al. Retrospective review of intrathecal hydromorphone dose range and complications. Pain Physician. 2023;26:E557–E565.
Al-Shurbaji A, Tokics L. The pharmacokinetics of ketobemidone in critically ill patients. Br J Clin Pharmacol. 2002;54:583–586.
Bondesson U, Arner S, Anderson P, et al. Clinical pharmacokinetics and oral bioavailability of ketobemidone. Eur J Clin Pharmacol. 1980;17:45–50.
Ngan Kee WD, Lam KK, Chen PP, et al. Epidural meperidine after cesarean section. A dose-response study. Anesthesiology. 1996;85:289–294.
Etches RC, Gammer TL, Cornish R. Patient-controlled epidural analgesia after thoracotomy: a comparison of meperidine with and without bupivacaine. Anesth Analg. 1996;83:81–86.
Stambaugh JE, Wainer IW, Sanstead JK, et al. The clinical pharmacology of meperidine--comparison of routes of administration. J Clin Pharmacol. 1976;16:245–256.
Halaszynski TM, Dai F, Huang Y. Donor hepatectomy surgery using ketamine to compliment analgesia and reduce morbidity—a retrospective chart review investigation. Turk J Anaesthesiol Reanim. 2018;46:28–37.
Nada EM, Alabdulkareem A. Morphine versus fentanyl patient-controlled analgesia for postoperative pain control in major hepatic resection surgeries including living liver donors: a retrospective study. Saudi J Anaesth. 2018;12:250–255.
Hausken J, Fretland AA, Edwin B, et al. Intravenous patient-controlled analgesia versus thoracic epidural analgesia after open liver surgery: a prospective, randomized, controlled, noninferiority trial. Ann Surg. 2019;270:193–199.
Kao CW, Wu SC, Lin KC, et al. Pain management of living liver donors with morphine with or without ketorolac. Transplant Proc. 2012;44:360–362.
Khan JS, Margarido C, Devereaux PJ, et al. Preoperative celecoxib in noncardiac surgery: a systematic review and meta-analysis of randomised controlled trials. Eur J Anaesthesiol. 2016;33:204–214.
Tsukano Y, Sugita M, Hirata N, et al. Future liver remnant volume is associated with postoperative fentanyl consumption following open donor hepatectomy: a retrospective multivariate analysis. J Anesth. 2022;36:731–739.
Adams MA, Andacoglu O, Crouch CE, et al.; ERAS4OLT.org Working Group. Does pre-operative counselling of the donor improve immediate and short-term outcomes after living liver donation? A review of the literature and expert panel recommendations. Clin Transplant. 2022;36:e14636.
Trzebicki J, Nicinska B, Blaszczyk B, et al. Thoracic epidural analgesia in anaesthesia for liver transplantation: the 10-year experience of a single centre. Ann Transplant. 2010;15:35–39.
Hausken J, Haugaa H, Hagness M, et al. Thoracic epidural analgesia for postoperative pain management in liver transplantation: a 10-year study on 685 liver transplant recipients. Transplant Direct. 2021;7:e648.
Milan ZB, Duncan B, Rewari V, et al. Subcostal transversus abdominis plane block for postoperative analgesia in liver transplant recipients. Transplant Proc. 2011;43:2687–2690.
Assefi M, Trillaud E, Vezinet C, et al. Subcostal transversus abdominis plane block for postoperative analgesia in liver transplant recipients: a before-and-after study. Reg Anesth Pain Med. 2023;48:352–358.
Gucyetmez B, Atalan HK, Aslan S, et al. Effects of intraoperative magnesium sulfate administration on postoperative tramadol requirement in liver transplantation: a prospective, double-blind study. Transplant Proc. 2016;48:2742–2746.
Knorr JP, Barlow A, Reinaker TS, et al. A single dose of pre-operative pregabalin reduces post-operative opioid use after orthotopic liver transplantation. Clin Transplant. 2021;35:e14319.
Kutzler HL, Gannon R, Nolan W, et al. Opioid avoidance in liver transplant recipients: reduction in postoperative opioid use through a multidisciplinary multimodal approach. Liver Transpl. 2020;26:1254–1262.
Lee TC, Bittel L, Kaiser TE, et al. Opioid minimization after liver transplantation: results of a novel pilot study. Liver Transpl. 2020;26:1188–1192.
Tong K, Nolan W, O’Sullivan DM, et al. Implementation of a multimodal pain management order set reduces perioperative opioid use after liver transplantation. Pharmacotherapy. 2019;39:975–982.
Pollok JM, Tinguely P, Berenguer M, et al.; ERAS4OLT.org collaborative. Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference. Lancet Gastroenterol Hepatol. 2023;8:81–94.
Demir B, Saritas S. Effect of hand massage on pain and anxiety in patients after liver transplantation: a randomised controlled trial. Complement Ther Clin Pract. 2020;39:101152.
Yu HC, Kleiman V, Kojic K, et al. Prevention and management of chronic postsurgical pain and persistent opioid use following solid organ transplantation: experiences from the Toronto General Hospital transitional pain service. Transplantation. 2022;107:1398–1405.
Rubin JB, Aby ES, Barman P, et al. Opioid use and risks in candidates and recipients of liver transplant. Liver Transpl. [Epub ahead of print.]. 2024. doi:10.1097/LVT.0000000000000388
doi: 10.1097/LVT.0000000000000388
Braun HJ, Schwab MP, Jin C, et al. Opioid use prior to liver transplant is associated with increased risk of death after transplant. Am J Surg. 2021;222:234–240.
Laks J, Alford DP. Treatment of opioid use disorder in patients with liver disease. Clin Liver Dis (Hoboken). 2024;23:e0207.
Jiao M, Greanya ED, Haque M, et al. Methadone maintenance therapy in liver transplantation. Prog Transplant. 2010;20:209–214; quiz 215.
Harrison TK, Kornfeld H, Aggarwal AK, et al. Perioperative considerations for the patient with opioid use disorder on buprenorphine, methadone, or naltrexone maintenance therapy. Anesthesiol Clin. 2018;36:345–359.
Kanchana TP, Kaul V, Manzarbeitia C, et al. Liver transplantation for patients on methadone maintenance. Liver Transpl. 2002;8:778–782.
Weinrieb RM, Barnett R, Lynch KG, et al. A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients. Liver Transpl. 2004;10:97–106.
Liu LU, Schiano TD, Lau N, et al. Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. Am J Transplant. 2003;3:1273–1277.
Kohan L, Potru S, Barreveld AM, et al. Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel. Reg Anesth Pain Med. 2021;46:840–859.
Hickey TR, Henry JT, Edens EL, et al. Perioperative management of extended-release buprenorphine. J Addict Med. 2023;17:e67–e71.